Literature DB >> 32449179

Mortality in Older Patients with COVID-19.

Hai-Lu Zhao1, Yan-Mei Huang2, Yi Huang1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32449179      PMCID: PMC7283633          DOI: 10.1111/jgs.16649

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


× No keyword cloud information.
To the Editor: Dr. Sun and colleagues report risk factors for mortality in 244 older patients with 2019 coronavirus disease (COVID‐19) in Wuhan, China. They found older age and lower lymphocyte count were independently associated with in‐hospital mortality (IHM) in both men and women who were aged 60 and older. This early retrospective study disclosed an IHM rate as high as 49.6% (number of deaths/cases = 121/244), substantially higher than 10.0% of the 1,474 COVID‐19 patients aged 65 and older from 169 hospitals in Asia, Europe, and North America, and 32.7% of the 1,425 COVID‐19 patients aged 60 and older in New York. Among the 5,700 COVID‐19 patients hospitalized in the New York metropolitan area, IHM rate was 15.8% (84/533), 32.2% (145/451), 54.3% (170/313), and 52.3% (67/128) for older adults aged 60 to 69, 70 to 79, 80 to 89, and 90 and older, respectively. Moreover, 94% of the 5,700 patients had at least one comorbidity including hypertension (56.6%) and diabetes (33.8%). These conditions increased the risk for in‐hospital death in those requiring invasive mechanical ventilation (IMV) and the intensive care unit (ICU). Chronic obstructive pulmonary disease (COPD) and underlying cardiovascular disorders were independent risk factors for IHM in patients with confirmed COVID‐19 infection. Because in‐hospital death, IMV, and ICU admission are the terminal events, the high IHM rate might mask any significant effects of risk factors such as diabetes mellitus, hypertension, coronary artery disease, and COPD. The independent association of lower lymphocyte count with in‐hospital death might be modified when including admission to ICU and IMV in further multivariable analyses. Generally, the IHM rate is much higher than the case fatality rate (CFR). CFR of those COVID‐19 patients aged 60 and older was 6.0% (829/13,909) in Mainland China and 12.3% (1,567/12,695) in Italy. The COVID‐19 patients aged 60 and older comprised largely 81.0% of the overall 1,023 deaths but fractionally 31.1% of the total 44,672 confirmed cases. Among the 44,672 confirmed COVID‐19 cases in Mainland China as of February 11, 2020, CFR was .6% (194/30,763), 3.6% (309/8,583), 8.0% (312/3,918), and 14.8% (208/1,408) for those aged 0 to 59, 60 to 69, 70 to 79s, and 80 and older, respectively. The corresponding CFR by age group in Italy confirmed COVID‐19 cases was .6% (57/9,817), 3.5% (139/3,971), 12.8% (578/4,516), and 20.2% (850/4,208), with a CFR of 12.3% (1,567/12,695) for all those 60 and older. As of May 19, 2020, IHM rate from the New York City Health Department was 31.7% (16,059/50,618) for all the patients, 47.9% for the patients aged 65 and older, and 17.8% for patients aged 0 to 64. All the IHM rates are much higher than the corresponding CFR (31.7% vs 8.4%, 47.9 vs 26.6%, and 17.8% vs 3.4%). Therefore, the risk factors for mortality might be different between hospitalized patients and confirmed cases. Consistently, age 65 and older is an independent risk factor for death, cardiovascular events, and terminal events requiring IMV and ICU admission. On April 13, 2020, the China Daily reported an announcement from the China National Health Commission that nearly 70% of the more than 3,000 COVID‐19 patients in Wuhan aged older than 80 years had recovered, achieving an IHM rate as low as 30% when considering that 90% and 40% of whom, respectively, had multiple comorbidities and critical illness. Wuhan, the Chinese city hit hardest by the outbreak, also had China’s oldest coronavirus survivors, seven patients who were older than 100 years, with the eldest 108, who had recovered and been discharged from hospitals. This is really an achievement with the input of medical resources including labor, materials, and financial resources, investment in nursing, psychological counseling, and multidisciplinary care during hospitalization up to 60 days. Last but not least, long‐term care for those aged 65 and older who were discharged from the hospital is also particularly critical to prevent future fatal infection, especially among those who have consciousness disorders and cognitive dysfunction, and are living in nursing homes. ,
  8 in total

1.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Authors:  Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

4.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.

Authors:  Mandeep R Mehra; Sapan S Desai; SreyRam Kuy; Timothy D Henry; Amit N Patel
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

5.  Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.

Authors:  Haiying Sun; Ruoqi Ning; Yu Tao; Chong Yu; Xiaoyan Deng; Caili Zhao; Silu Meng; Fangxu Tang; Dong Xu
Journal:  J Am Geriatr Soc       Date:  2020-05-12       Impact factor: 7.538

6.  CHINA'S OLDEST CORONAVIRUS SURVIVORS.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jian Shen; Yi Huang; Hai-Lu Zhao
Journal:  J Am Geriatr Soc       Date:  2020-04-08       Impact factor: 5.562

7.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

Authors:  Temet M McMichael; Dustin W Currie; Shauna Clark; Sargis Pogosjans; Meagan Kay; Noah G Schwartz; James Lewis; Atar Baer; Vance Kawakami; Margaret D Lukoff; Jessica Ferro; Claire Brostrom-Smith; Thomas D Rea; Michael R Sayre; Francis X Riedo; Denny Russell; Brian Hiatt; Patricia Montgomery; Agam K Rao; Eric J Chow; Farrell Tobolowsky; Michael J Hughes; Ana C Bardossy; Lisa P Oakley; Jesica R Jacobs; Nimalie D Stone; Sujan C Reddy; John A Jernigan; Margaret A Honein; Thomas A Clark; Jeffrey S Duchin
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

  8 in total
  7 in total

1.  High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020.

Authors:  Matt Feaster; Ying-Ying Goh
Journal:  Emerg Infect Dis       Date:  2020-07-02       Impact factor: 6.883

2.  Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid.

Authors:  Rafael Bielza; Juan Sanz; Francisco Zambrana; Estefanía Arias; Eduardo Malmierca; Laura Portillo; Israel J Thuissard; Ana Lung; Marta Neira; María Moral; Cristina Andreu-Vázquez; Ana Esteban; Marcela Irma Ramírez; Laura González; Guillermo Carretero; Ricardo Vicente Moreno; Pilar Martínez; Javier López; Mar Esteban-Ortega; Isabel García; María Antonia Vaquero; Ana Linares; Ana Gómez-Santana; Jorge Gómez Cerezo
Journal:  J Am Med Dir Assoc       Date:  2020-12-11       Impact factor: 4.669

3.  The Association Between BMI and Inpatient Mortality Outcomes in Older Adults With COVID-19.

Authors:  Akwe Nyabera; Sofia Lakhdar; Matthew Li; Theo Trandafirescu; Sakina Ouedraogo Tall
Journal:  Cureus       Date:  2020-10-26

4.  Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study.

Authors:  Mark James Rawle; Deborah Lee Bertfield; Simon Edward Brill
Journal:  Aging Med (Milton)       Date:  2020-09-17

5.  COVID-19 Mortality in Patients Aged 80 and over Residing in Nursing Homes-Six Pandemic Waves: OCTA-COVID Study.

Authors:  Claudia Ruiz-Huerta; Marcelle V Canto; Carmen Ruiz; Ildefonso González; Isabel Lozano-Montoya; Maribel Quezada-Feijoo; Francisco J Gómez-Pavón
Journal:  Int J Environ Res Public Health       Date:  2022-09-22       Impact factor: 4.614

6.  Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response.

Authors:  Bruce A Ruscio; Peter Hotez
Journal:  Vaccine       Date:  2020-10-21       Impact factor: 3.641

7.  Insufficient evidence for vitamin D use in COVID-19: A rapid systematic review.

Authors:  Aline Pereira da Rocha; Alvaro Nagib Atallah; José Mendes Aldrighi; Andréa Larissa Ribeiro Pires; Maria Eduarda Dos Santos Puga; Ana Carolina Pereira Nunes Pinto
Journal:  Int J Clin Pract       Date:  2021-08-18       Impact factor: 3.149

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.